Mates, Sharon,,Fienberg, Allen A.,Wennogle, Lawrence P.
申请号：
AU2015218433
公开号：
AU2015218433A1
申请日:
2015.08.25
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
#$%^&*AU2015218433A120150910.pdf#####ABSTRACT Use of a particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals and pharmaceutical compositions comprising them for the treatment of one or 5 more disorders involving the 5-HT2A, SERT and/or dopamine D2 pathways are disclosed. In addition, the compounds may be combined with other therapeutic agents for the treatment of one or more sleep disorders, depression, psychosis, dyskinesias, and/or Parkinsons disease or any combinations.
